New diabetes clinical trial: Low-dose Arginine-vasopressin Supplementation on Post-transplant Acute Kidney Injury After Liver Transplantation (AVENIR Trial)

Published on: April 02, 2024 at 11:00PM
Conditions: Acute Kidney Injury Post Liver Transplantation
Interventions: Drug: Arginine vasopressin; Drug: Norepinephrine
Sponsors: Assistance Publique - Hôpitaux de Paris
Not yet recruiting
https://ift.tt/JndLp82